In RA, there is a disproportion involving receptor activator of nuclear factor κΒ, which is highly expressed by immune cells and fibroblasts, and its evasion receptor, osteoprotegerin, which causes excessive bone loss and degradation [3,38]. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.